GT Molecular Wins CDC’s National Wastewater Surveillance System Multi-Pathogen Assay Development Contract

FORT COLLINS, Colo., Sept. 12, 2024 /PRNewswire/ — GT Molecular, Inc., a company providing ultrasensitive PCR assays for wastewater-based epidemiology, cancer research, and pathogen detection, was awarded the Center for Disease Control’s (CDC) National Wastewater Surveillance System…